Ten international projects have been selected for the second edition of CRAASH Barcelona and Aniling is one of them. CRAASH is the business acceleration programme organized by Biocat and CIMIT (Boston). Aniling is a spin-off company of the IGTP, which has developed a method for analysing the genome and epigenome of a patient simultaneously, an advance in personalized medicine for both research and clinical settings.
At the IGTP TODAY
The IGTP is a partner in an international project to improve personalized treatments for childhood cancer using artificial intelligence tools
This year the Childhood Liver Oncology Group (c-LOG) led by Carolina Armengol was one of 21 prestigious International partners from 11 countries joining in the Individualized Paediatric Cure (iPC) Project. The project has 15 million euros funding for four years and is led by IBM in Switzerland and Technikon in Austria.
Researchers at the IGTP identify new candidate biomarkers for the initial stages of childhood diabetes type 1
The Immunology of Diabetes Group at the IGTP has published its first results for their new research line on diabetes type 1 (T1D) in children, focussed on the mechanisms of the re-establishment of tolerance in children at the start of the disease and the definition of new biomarkers for its remission.
This year the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) has published a protocol for Size-Exclusion Chromatography for separating extracellular vesicles from different biological fluids and a review of the current techniques available.
New financing from the Catalan NF2 Patients Association for Research into personalized medicine for Neurofibromatosis Type 2
Can Ruti has been awarded a research project by the Spanish Federation for Rare Diseases (FEDER) Foundation in their fourth call for research projects. The winning project, led by Dr Ignacio Blanco and Dr Elisabeth Castellanos, from the Germans Trias I Pujol Hospital and Institute respectively, is one of five financed by the foundation this year. The research will focus personalized attention for Neurofibromatosis type 2 (NF2) patients to optimize evaluation of their quality of life and refine their classification during diagnosis.
Elisa Martró, leader of the Clinical Virology and New Diagnostic Approaches Research Group at the Microbiology Service of the Germans Trias i Pujol Hospital, has been awarded with one of the five projects granted in the First Edition of the Gilead projects for Micro-elimination of Hepatitis C in Spain and evaluated by the Spanish Liver Research Association (AEEH).
In an in vitro study researchers have shown how the nanoparticles are more effective than antibiotics alone. In the future, the nanoparticles will be administered orally as a non-invasive treatment that is much more acceptable to patients.
The IGTP and the Germans Trias Hospital face the spotlight for rare diseases again. This year our professionals are joining World Rare Disease Day on the last day of February to highlight these diseases and shine a light on the research activities in the field on campus.
The Cellular and Molecular Neurobiology Research Group, led by Teresa Gasull at the IGTP has a mission to carry out basic and translational research into strokes. This week they have published a review of recent advances in the field, which includes the role of the ferroptosis in stroke-induced neurodegeneration and includes references to their own recent publications in the field.
The Digestive Inflammatory Pathology Research Group awarded the prize for best research project at the Catalan Digestive Medicine Conference
A study by the Digestive Inflammatory Pathology Research Group at the IGTP was awarded the best basic-translational research study in the Catalan Digestive Medicine Conference 2019. The study presented by Dr Violeta Lorén is within one of the main research lines of the group and centres on understanding, predicting and solving one of the main complications arising from therapy for patients with ulcerative colitis: the failure of glucocorticoid treatment.